From the Department of Psychiatry & Behavioral Sciences (Houghton, Uhde, Borckardt, Cortese), Medical University of South Carolina, Charleston, South Carolina; and Psychological and Brain Sciences Department (Houghton), Texas A&M University, College Station, Texas.
Psychosom Med. 2019 May;81(4):389-395. doi: 10.1097/PSY.0000000000000679.
Enhanced odor sensitivity is a phenomenon that potentially underlies conditions such as multiple chemical sensitivity (MCS). Currently, there are no treatments that have been shown to effectively decrease odor sensitivity. Given similarities of odor hypersensitivity/MCS to pain sensitization disorders such as fibromyalgia, there may be a potential for interventions that improve pain tolerance to modulate odor sensitivity.
This exploratory study randomized 72 healthy community adult volunteers to receive one of six treatments in between two assessments of thermal pain tolerance and odor threshold. Participants were randomized to receive either cathodal, anodal, or sham transcranial direct current stimulation (tDCS) aimed at dorsolateral prefrontal cortex. In addition, participants were provided a brief cognitive behavioral intervention (CBI) for pain consisting of task framing, cognitive restructuring, and distraction technique training, or a control intervention consisting of information about pain.
Persons who received a brief CBI showed significantly increased odor thresholds (reduced sensitivity) during intervention (F (1,62) = 7.29, p = .009, ηp = .11), whereas the control intervention was not associated with altered odor thresholds. Moreover, in those who received brief CBI, more severe anxiety associated with larger reductions in odor sensitivity (ρ = .364, p = .035). There was no effect of tDCS (F (2,62) = .11, p = .90) nor interaction between tDCS and CBI (F (2,62) = .32, p = .73).
Given the connection between anxiety and MCS, results suggest that CBT techniques for somatic processes may show promise in treating conditions characterized by increased sensitivity to odors (e.g., MCS).
增强的嗅觉敏感性是一种潜在的现象,可能是多种化学敏感性(MCS)等病症的基础。目前,尚无有效的治疗方法可以降低嗅觉敏感性。鉴于嗅觉过敏/MCS 与纤维肌痛等疼痛敏感障碍的相似性,可能存在一种通过提高疼痛耐受力来调节嗅觉敏感性的潜在干预方法。
这项探索性研究将 72 名健康社区成年志愿者随机分为六组中的一组,在两次热痛耐受力和嗅觉阈值评估之间接受一种治疗。参与者被随机分配接受经颅直流电刺激(tDCS)的阴极、阳极或假刺激,以靶向背外侧前额叶皮质。此外,还为参与者提供了一个简短的疼痛认知行为干预(CBI),包括任务框架、认知重构和分散技术训练,或一个关于疼痛的对照干预。
接受简短 CBI 的人在干预期间嗅觉阈值显著增加(敏感性降低)(F(1,62)= 7.29,p =.009,ηp =.11),而对照干预则与嗅觉阈值的改变无关。此外,在接受简短 CBI 的人中,与更大的嗅觉敏感性降低相关的焦虑更严重(ρ=.364,p =.035)。tDCS 无影响(F(2,62)=.11,p =.90),tDCS 和 CBI 之间也没有相互作用(F(2,62)=.32,p =.73)。
鉴于焦虑与 MCS 之间的联系,结果表明,针对躯体过程的 CBT 技术可能有望治疗以对气味敏感性增加为特征的病症(例如 MCS)。